Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-05-03
2005-05-03
Ungar, Susan (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S094000, C536S023100, C536S024300, C536S024310
Reexamination Certificate
active
06887660
ABSTRACT:
Compounds and methods for diagnosing prostate cancer are provided. The inventive compounds include polypeptides containing at least a portion of a prostate tumor protein. The inventive polypeptides may be used to generate antibodies useful for the diagnosis and monitoring of prostate cancer. Nucleic acid sequences for preparing probes, primers, and polypeptides are also provided.
REFERENCES:
patent: 5786148 (1998-07-01), Bandman et al.
patent: 6130043 (2000-10-01), Billing-Medel et al.
patent: 6252047 (2001-06-01), Billing-Medel et al.
patent: 20020086301 (2002-07-01), Billing-Medel et al.
patent: 652 014 (1995-05-01), None
patent: WO 9314755 (1993-08-01), None
patent: WO 9325224 (1993-12-01), None
patent: WO 9409820 (1994-05-01), None
patent: WO 9504548 (1995-02-01), None
patent: WO 9530758 (1995-11-01), None
patent: WO 9621671 (1996-07-01), None
Harris et al. J. of The Am Society of Nephrology 6:1125-33, 1995.*
Ahn et al. Nature Genetics 3(4):283-91, 1993.*
Cawthon et al. Genomics 9(3)446-60, 1991.*
MPSRCH search report, 2003, us-09-030-606-110.res, pp. 5-6, 9-10.*
Sambrook et al, eds, 1989, Molecular cloning, a Laboratory manual, 2nd ed, Cold Spring Harbor Laboratoy Press, Cold Spring Harbor, p. 11.8.*
Gelmini, S et al, 2001, Clin Chem Lab Med, 39(5): 385-391.*
Kibel, AS et al, 2000, J urol, 164(1): 192-6.*
Ren, C et al, 1998, Cancer Res, 58(6): 1285-90.*
Gingrich, JR et al, 1996, Cancer res, 56(18): 4096-4102.*
Corey E et al. Clinical Chemistry 43(3): 443-452, 1997.*
Schmidt, S., J. Comparative Neurology, 430(2): 160-171, 2001.*
Alexeyev et al., “Improved antibiotic-resistance gene cassettes and omega elements forEscherichia colivector construction and in vitro deletion/insertion mutagenesis,”Gene 160:63-67, 1995.
Blok et al., “Isolation of cDNAs That Are Differentially Expressed Between Androgen-Dependent and Androgen-Independent Prostate Carcinoma Cells Using Differential Display PCR,”The Prostate 26: 213-224, 1995.
Database EMBL Accession No. AA453562, Jun. 11, 1997, Hillier et al., “Homo Sapiens cDNA Clone 788180.”
El-Shirbiny, Prostatic Specific Antigen,Advances In Clinical Chemistry 31: 99-133, 1994.
Robson et al., “Identification of prostatic androgen regulated genes using the differential display technique,”Proceedings Of The American Association For Cancer Research Meeting 86, 36: p. 266, Abstract No. 1589, 1995.
Short et al., “λZAP: a bacteriophage λ expression vector with in vivo excision properties,”Nucleic Acids Research 16(15): 7583-7600, 1988.
Dillon Davin C.
Xu Jiangchun
Corixa Corporation
Davis Minh-Tam
Seed IP Law Group PLLC
Ungar Susan
LandOfFree
Compounds for immunodiagnosis of prostate cancer and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for immunodiagnosis of prostate cancer and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for immunodiagnosis of prostate cancer and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3413108